-

Pulse8 Receives NCQA Measure Certification™ for HEDIS® MY2022 for Qualit8™, a Veradigm Network Solution

CHICAGO--(BUSINESS WIRE)--Pulse8 is thrilled to announce that Qualit8, a Veradigm Network Solution, has achieved MY2022 Measure Certification from the National Committee for Quality Assurance (NCQA) for the third consecutive year. Veradigm® is a leading provider of healthcare data, analytics and technology solutions and a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX). By earning NCQA Measure Certification, the industry’s most rigorous assessment, Qualit8 demonstrates a commitment to delivering value and administrative efficiency to health plan customers.

Combining our Qualit8 Quality Improvement Analytics with an NCQA-Certified HEDIS® Measurement Certification Program allows health plans to gain line of sight into HEDIS measure performance and optimize gap closure workflows towards maximum efficiency.

Pulse8’s NCQA-Certified HEDIS MY2022 Measure program includes:

  • HEDIS Health Plan Measures Certification
  • Allowable Adjustment Measures Certification
  • ECDS Measures Certification
  • Hybrid Sampling Certification

“This certification is a prime example of how Veradigm continues to deliver industry-leading, transparent analytics to our health plan customers,” says President and Chief Commercial Officer Tom Langan. “As a Veradigm Network solution, Qualit8’s NCQA-Certified HEDIS® Measurement and Reporting Software provides health plans with a higher level of value by helping reduce healthcare spending, waste and improving administrative efficiency.”

You can learn more about Qualit8 Certification and Veradigm’s full suite of products at https://veradigm.com/quality-analytics/.

NCQA is a private, non-profit organization dedicated to improving health care quality. NCQA Measure Certification Program™ is a trademark of the National Committee for Quality Assurance (NCQA). HEDIS® is a registered trademark of the of the National Committee for Quality Assurance (NCQA).

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. Some healthcare technology companies deliver clinical data for biopharma and health plans, some help turn that data into insights, others serve healthcare providers directly by providing point-of-care clinical software and patient outreach platforms. Veradigm does it all. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.

For more information on Veradigm, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2022 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Contacts

Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@allscripts.com

Media:
Katie Wilson
802-264-6212
Katherine.Wilson@veradigm.com

Allscripts Healthcare, LLC Logo
Allscripts Healthcare, LLC Logo

Allscripts Healthcare, LLC

NASDAQ:MDRX

Release Versions

Contacts

Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@allscripts.com

Media:
Katie Wilson
802-264-6212
Katherine.Wilson@veradigm.com

More News From Allscripts Healthcare, LLC

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

CHICAGO--(BUSINESS WIRE)--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research. Built on Veradigm’s FollowMyHealth pat...

Veradigm to Release Business Update February 17th and Host Investor Call February 18th

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company’s update at 8:00 a.m. Eastern Time on February 18, 2026. Update Call Details Veradigm plans to issue a press release after the c...

Veradigm Extends Stockholder Rights Plan

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that its Board of Directors (the “Board”) has approved an amendment to extend the Company’s existing Stockholder Rights Plan to December 31, 2026 (the “Rights Plan”). The Board's decision to extend the Rights Plan is based on its determination that many of the underlying risks and conditions that existed upon the initial adoption of the Right...
Back to Newsroom